Combined oral contraceptives in improving quality of young women’s lives
https://doi.org/10.33667/2078-5631-2019-1-1(376)-15-18
Abstract
Compliance with the use of combined hormonal contraceptive drugs containing drospirenone is presented. The use of such drugs enhances the use of hormonal contraception. The distinctive features of the drugs are considered: reliable contraception, reduced severity of side effects, additional positive preventive and curative effects.
About the Authors
A. L. Tikhomirov
Moscow State Medical and Stomatological University n.a. A. I. Evdokimov
Russian Federation
Russian Federation
T. A. Yudina
SM-Clinic Co
Russian Federation
Russian Federation
D. I. Burchakov
Higher Medical School
Russian Federation
Russian Federation
References
1. Lobo RA с соавт. Am J Obstet Gynecol. 1994; 170: 1499-1507.
2. Guengerich FP. Life Sci. 1990; 47: 1981-1988.
3. Тихомиров А.Л. и соавт. Гормональная терапия женщин с андрогензависимыми дерматопатиями. Трудный пациент // 2017; № 8-9, том 15: 17-21.
4. Sitruk-Ware R., Nath A. The use of newer progestins for contraception // Contraception.- 2010; 82: 410-417.
5. Schindler AE, Campagnoli C, Druckmann R, et al. Classification and pharmacology of progestins // Maturitas.- 2008; 61: 171-80.
Review
For citations:
Tikhomirov A.L., Yudina T.A., Burchakov D.I. Combined oral contraceptives in improving quality of young women’s lives. Medical alphabet. 2019;1(1):15-18. (In Russ.) https://doi.org/10.33667/2078-5631-2019-1-1(376)-15-18
Views:
411
Email this article 